Table 3.
Lesion severity (in %) in dogs treated once with oral or topical fluralaner (Day 0) or twice with oral sarolaner (Days 0 and 28). Only the worst lesion was considered in a dog with more than one lesion
| Day 0 | Day 28 | Day 56 | Day 84 | |
|---|---|---|---|---|
| Oral fluralaner | ||||
| None | 0.0 | 48.1 | 85.2 | 98.1 |
| Mild | 27.8 | 48.2 | 14.8 | – |
| Moderate | 48.1 | 3.7 | – | – |
| Severe | 24.1 | – | – | 1.9a |
| Topical fluralaner | ||||
| None | 0.0 | 41.3 | 89.1 | 100.0 |
| Mild | 13.0 | 52.2 | 8.7 | – |
| Moderate | 56.5 | 4.3 | 2.2 | – |
| Severe | 30.5 | 2.2 | – | – |
| Oral sarolaner | ||||
| None | 3.9 | 42.3 | 84.6 | 100.0 |
| Mild | 7.7 | 38.5 | 11.5 | – |
| Moderate | 57.7 | 19.2 | 3.9 | – |
| Severe | 30.7 | – | – | – |
aSkin lesion assessed as trunk pyoderma unrelated to sarcoptic mange